| 2023 |
Prof David Mackey AO |
What is the normal range if intraocular pressure in children and young adults, and does it predict later glaucoma? |
| 2022 |
A/Prof Owen Siggs |
Genomic Risk Stratification to Improve Glaucoma Suspect Triage in Rural Primary Care |
| 2021 |
Professor Ewa Goldys
University of New South Wales |
The fluorescent Hyperspectral Imaging (fHSI) technology, a novel imaging tool for the early detection and monitoring of glaucoma. |
| 2019 |
Dr Flora Hui
Centre for Eye Research Australia (CERA) |
TAMING Glaucoma Trial (Targeting Metabolic Insufficiency in Glaucoma with Nicotinamide) |
| 2019 |
Dr George Kong
Royal Victorian Eye and Ear Hospital |
Clinical trial to examine the validity of home monitoring using the world’s first software app for tablet devices for glaucoma patients. |
| 2019 |
Prof Jamie Craig
Flinders University |
Population level screening aims to provide evidence which drives early intervention to the highest risk individuals before vision loss occurs. |
| 2018 |
Flinders University |
TARRGET |
| 2017 |
Flinders University |
TARRGET |
| 2016 |
Flinders University |
TARRGET |
| 2016 |
Dr Kathryn Burdon
Ms Emmanuelle Souzeau |
Identifying genetic causes of primary congenital glaucoma in Australia |
| 2016 |
Prof Jonathan Crowston
Dr Ian Trounce |
Oxidative Phosphorylation defects and the optic nerve response to acute IOP injury in the xenomitochondrial mouse |
| 2015 |
Westmead Hospital |
|
| 2015 |
A/Prof Robert Casson |
Bioenergetic-Based Neuroprotection for the Treatment of Retinal and Optic |
| 2014 |
Prof Jamie Craig
Dr Alex Hewitt |
Proteomic and Genomic Strategies to Identify the Molecular Basis of PEX |
| 2013 |
Prof Glen Gole
Dr Nigel Barnett
Prof Steven Bottle |
Evaluating a novel (two-way, ie reversible) technique to measure oxidation (or reduction) in retinal cells in an experimental glaucoma model |
| 2013 |
Dr Alex Hewitt
Dr Mirella Dottori
Dr Bryony Nayagam |
Developing a patient-specific model for glaucoma |
| 2012 |
Dr Glyn Chidlow |
Investigations into optic nerve injury in a rat model of glaucoma |
| 2012 |
Dr Kathryn Burdon
Prof Jamie Craig
Dr James Muecke
Dr Adam Rudkin
Dr Jillian Nicholl |
Genetic causes of childhood blindness in Sri Lanka and Cambodi |
| 2011 |
A/Prof Robert Casson |
Can Glucose Eye Drops Improve Vision in Glaucoma |
| 2011 |
Dr Kathryn Burdon |
Genetic Investigations of Central Corneal Thickness in Relation to Blinding Glaucoma |
| 2010 |
Ms F O’Hare |
Characteristics of auditory function in individuals with glaucoma |
| 2010 |
Prof Jonathan Crowston
Dr Paul Healey |
Regulating wound healing after glaucoma filtration surgery by priming Tenon’s fibroblast for apoptosis. |
| 2010 |
Dr A. Martins
Prof Stuart Graham
Dr Alexander Klistorner |
Spectral (Blue-Yellow) Objective Perimetry in Normal and Diseased States |
| 2009 |
Dr John Wood
Dr Glyn Chidlow |
The Role of Tau in Experimental Glaucoma |
| 2009 |
Prof David Mackey |
The Twin Eye Studies in Tasmania to investigate genetic and environmental contributions to glaucoma and other eye diseases |
| 2009 |
Dr Colin I Clement |
Hyperhomocystinaemia in Glaucoma |
| 2008 |
Dr Glyn Chidlow
A/Prof Robert Casson |
The Role of Osteopontin in the Retina |
| 2008 |
A/Prof Robert Casson |
Bioenergetic-Based Neuroprotection for the Treatment of Retinal and Optic |
| 2007 |
Dr Simon Skalicky |
Glaucoma and Depression |
| 2007 |
Prof Peter McCluskey
Alex Dempster
Prof ACB (Tony) Molteno
Prof Denis Wakefield |
The Role of Matrix Metallooproteinases in the Development of Filtration Blebs following Molteno Valve Insertion |
| 2006 |
Prof Minas T Coroneo
Dr Agar Ashish
Dr Mark Hill |
The Effects of Pressure on Retinal Ganglion Cell Survival In-Vitro |
| 2005 |
Mr Michael Ward
A/Prof Ross McKinnon |
Genetic determinants of beta-blocker eye drop efficacy in glaucoma patient |
| 2004 |
Prof Jamie Craig
Dr Nick Voelcker |
Miniaturised Implantable Sensors for Eye Pressure Measurement |
